• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Modeling autosomal dominant Alzheimer's disease with machine learning.基于机器学习的常染色体显性阿尔茨海默病建模。
Alzheimers Dement. 2021 Jun;17(6):1005-1016. doi: 10.1002/alz.12259. Epub 2021 Jan 21.
2
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.甘特奈单抗在DIAN-TU-001试验中对神经影像学生物标志物的区域效应。
Alzheimers Dement. 2025 Jul;21(7):e70347. doi: 10.1002/alz.70347.
3
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
4
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).γ-分泌酶活性、临床特征和常染色体显性阿尔茨海默病的生物标志物:显性遗传性阿尔茨海默病网络观察研究(DIAN-OBS)的横断面和纵向分析。
Lancet Neurol. 2024 Sep;23(9):913-924. doi: 10.1016/S1474-4422(24)00236-9. Epub 2024 Jul 26.
5
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
6
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).(11)使用C-PIB-PET对轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆进行早期诊断。
Cochrane Database Syst Rev. 2014 Jul 23;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2.
7
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.常染色体显性遗传与散发性早发型阿尔茨海默病的分子神经影像学
Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024.
8
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.常染色体显性阿尔茨海默病淀粉样β负担的变异依赖性异质性:一项观察性研究的横断面和纵向分析。
Lancet Neurol. 2022 Feb;21(2):140-152. doi: 10.1016/S1474-4422(21)00375-6.
9
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
10
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.性别和载脂蛋白 E ε4 等位基因对早发性阿尔茨海默病患者脑萎缩、淀粉样 PET 和 tau PET 负荷的影响。
Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S49-S63. doi: 10.1002/alz.13403. Epub 2023 Jul 26.

引用本文的文献

1
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease.阿尔茨海默病中脑脊液、血浆和神经影像学生物标志物效用的比较。
Brain Commun. 2024 Mar 15;6(2):fcae081. doi: 10.1093/braincomms/fcae081. eCollection 2024.
2
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40.利用脑脊液和血浆中的Aβ42/Aβ40预测连续淀粉样蛋白PET值。
Alzheimers Dement (Amst). 2023 Mar 2;15(1):e12405. doi: 10.1002/dad2.12405. eCollection 2023 Jan-Mar.
3
Detection of Association Features Based on Gene Eigenvalues and MRI Imaging Using Genetic Weighted Random Forest.基于基因特征值和 MRI 成像的遗传加权随机森林关联特征检测。
Genes (Basel). 2022 Dec 12;13(12):2344. doi: 10.3390/genes13122344.
4
A Perspective: Challenges in Dementia Research.一个观点:痴呆症研究中的挑战。
Medicina (Kaunas). 2022 Sep 28;58(10):1368. doi: 10.3390/medicina58101368.
5
Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease.基于协方差的功能连接与基于相关的功能连接可区分健康衰老与阿尔茨海默病。
Neuroimage. 2022 Nov 1;261:119511. doi: 10.1016/j.neuroimage.2022.119511. Epub 2022 Jul 30.
6
Biomarker clustering in autosomal dominant Alzheimer's disease.常染色体显性阿尔茨海默病的生物标志物聚类。
Alzheimers Dement. 2023 Jan;19(1):274-284. doi: 10.1002/alz.12661. Epub 2022 Apr 1.
7
The Road to Personalized Medicine in Alzheimer's Disease: The Use of Artificial Intelligence.阿尔茨海默病个性化医疗之路:人工智能的应用
Biomedicines. 2022 Jan 29;10(2):315. doi: 10.3390/biomedicines10020315.
8
A double-dichotomy clustering of dual pathology dementia patients.双病理痴呆患者的双重二分法聚类
Cereb Circ Cogn Behav. 2021;2. doi: 10.1016/j.cccb.2021.100011. Epub 2021 Apr 2.
9
, , and Variants in Alzheimer's Disease: Systematic Re-evaluation According to ACMG Guidelines.阿尔茨海默病中的 、 和 变异:根据美国医学遗传学与基因组学学会指南进行的系统重新评估
Front Aging Neurosci. 2021 Jun 18;13:695808. doi: 10.3389/fnagi.2021.695808. eCollection 2021.

本文引用的文献

1
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using F-FDG PET of the Brain.利用大脑 F-FDG PET 预测阿尔茨海默病诊断的深度学习模型。
Radiology. 2019 Feb;290(2):456-464. doi: 10.1148/radiol.2018180958. Epub 2018 Nov 6.
2
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.遗传性阿尔茨海默病的纵向认知和生物标志物变化。
Neurology. 2018 Oct 2;91(14):e1295-e1306. doi: 10.1212/WNL.0000000000006277. Epub 2018 Sep 14.
3
Current Applications and Future Impact of Machine Learning in Radiology.机器学习在放射学中的当前应用和未来影响。
Radiology. 2018 Aug;288(2):318-328. doi: 10.1148/radiol.2018171820. Epub 2018 Jun 26.
4
Data-driven models of dominantly-inherited Alzheimer's disease progression.基于数据驱动的显性遗传性阿尔茨海默病进展模型。
Brain. 2018 May 1;141(5):1529-1544. doi: 10.1093/brain/awy050.
5
Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.在常染色体显性阿尔茨海默病风险人群中,pCASL-MRI 与 FDG-PET 和 PiB-PET 的区域相关性。
Neuroimage Clin. 2017 Dec 6;17:751-760. doi: 10.1016/j.nicl.2017.12.003. eCollection 2018.
6
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.常染色体显性阿尔茨海默病家系个体中神经影像学生物标志物变化的空间模式:一项纵向研究。
Lancet Neurol. 2018 Mar;17(3):241-250. doi: 10.1016/S1474-4422(18)30028-0. Epub 2018 Feb 1.
7
Comparison of [F]Flutemetamol and [C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals.比较[F]氟替美莫和[C]匹兹堡化合物-B 在认知正常的年轻、认知正常的老年和阿尔茨海默病痴呆个体中的应用。
Neuroimage Clin. 2017 Aug 14;16:295-302. doi: 10.1016/j.nicl.2017.08.011. eCollection 2017.
8
Multi-Kernel Learning with Dartel Improves Combined MRI-PET Classification of Alzheimer's Disease in AIBL Data: Group and Individual Analyses.使用达特尔的多核学习改善了AIBL数据中阿尔茨海默病的MRI-PET联合分类:组分析和个体分析
Front Hum Neurosci. 2017 Jul 25;11:380. doi: 10.3389/fnhum.2017.00380. eCollection 2017.
9
Machine Learning for Medical Imaging.用于医学成像的机器学习
Radiographics. 2017 Mar-Apr;37(2):505-515. doi: 10.1148/rg.2017160130. Epub 2017 Feb 17.
10
Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.机器学习在轻度认知障碍和阿尔茨海默病动脉自旋标记中的应用。
Radiology. 2016 Dec;281(3):865-875. doi: 10.1148/radiol.2016152703. Epub 2016 Jul 6.

基于机器学习的常染色体显性阿尔茨海默病建模。

Modeling autosomal dominant Alzheimer's disease with machine learning.

机构信息

Washington University in St. Louis, St. Louis, Missouri, USA.

University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

出版信息

Alzheimers Dement. 2021 Jun;17(6):1005-1016. doi: 10.1002/alz.12259. Epub 2021 Jan 21.

DOI:10.1002/alz.12259
PMID:33480178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8195816/
Abstract

INTRODUCTION

Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease.

METHODS

Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein ε4 (APOE ε4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status.

RESULTS

The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R  = 0.95), fluorodeoxyglucose (R  = 0.93), and atrophy (R  = 0.95) in mutation carriers compared to non-carriers.

DISCUSSION

Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.

摘要

简介

使用机器学习模型发现常染色体显性阿尔茨海默病的新疾病轨迹。

方法

从显性遗传性阿尔茨海默病网络中采集了 131 名突变携带者和 74 名非携带者的纵向结构磁共振成像、淀粉样蛋白正电子发射断层扫描(PET)和氟脱氧葡萄糖 PET;两组在年龄、教育程度、性别和载脂蛋白 E4(APOE ε4)方面相匹配。训练深度神经网络以预测每种模态的疾病进展。Relief 算法确定了突变状态的最强预测因子。

结果

Relief 算法确定尾状核、扣带回和楔前叶是所有模态中最强的预测因子。与非携带者相比,该模型在预测未来匹兹堡化合物 B(R = 0.95)、氟脱氧葡萄糖(R = 0.93)和萎缩(R = 0.95)方面,对突变携带者的预测结果非常准确。

讨论

结果表明淀粉样蛋白呈类正弦轨迹,代谢呈双相反应,体积逐渐下降,疾病进展主要发生在皮质下、中额和后顶叶区域。